(Q51952581)

English

Fluvoxamine in obsessive-compulsive disorder: similar efficacy but superior tolerability in comparison with clomipramine.

scientific article published in August 2001

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

18 April 2018

http://europepmc.org/abstract/MED/12404554

Fluvoxamine in obsessive-compulsive disorder: similar efficacy but superior tolerability in comparison with clomipramine. (English)

1 reference

Europe PubMed Central

PubMed publication ID

18 April 2018

http://europepmc.org/abstract/MED/12404554

1 reference

based on heuristic

inferred from title

obsessive-compulsive disorder

1 reference

based on heuristic

inferred from title

author name string

Emanuela Mundo

1

1 reference

Europe PubMed Central

PubMed publication ID

18 April 2018

http://europepmc.org/abstract/MED/12404554

Frédéric Rouillon

2

1 reference

Europe PubMed Central

PubMed publication ID

18 April 2018

http://europepmc.org/abstract/MED/12404554

M. Luisa Figuera

3

1 reference

Europe PubMed Central

PubMed publication ID

18 April 2018

http://europepmc.org/abstract/MED/12404554

Michael Stigler

4

1 reference

Europe PubMed Central

PubMed publication ID

18 April 2018

http://europepmc.org/abstract/MED/12404554

publication date

1 August 2001

1 reference

Europe PubMed Central

PubMed publication ID

18 April 2018

http://europepmc.org/abstract/MED/12404554

Human Psychopharmacology

1 reference

Europe PubMed Central

PubMed publication ID

18 April 2018

http://europepmc.org/abstract/MED/12404554

16

1 reference

Europe PubMed Central

PubMed publication ID

18 April 2018

http://europepmc.org/abstract/MED/12404554

6

1 reference

Europe PubMed Central

PubMed publication ID

18 April 2018

http://europepmc.org/abstract/MED/12404554

461-468

1 reference

Europe PubMed Central

PubMed publication ID

18 April 2018

http://europepmc.org/abstract/MED/12404554

The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability

1 reference

https://api.crossref.org/works/10.1002%2FHUP.317

21 January 2018

The Yale-Brown Obsessive Compulsive Scale. II. Validity

1 reference

https://api.crossref.org/works/10.1002%2FHUP.317

21 January 2018

Efficacy and tolerability of serotonin transport inhibitors in obsessive-compulsive disorder. A meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2FHUP.317

21 January 2018

Development of a Rating Scale for Primary Depressive Illness

1 reference

https://api.crossref.org/works/10.1002%2FHUP.317

21 January 2018

The epidemiology of obsessive-compulsive disorder in five US communities.

1 reference

https://api.crossref.org/works/10.1002%2FHUP.317

21 January 2018

Lifetime Prevalence of Specific Psychiatric Disorders in Three Sites

1 reference

https://api.crossref.org/works/10.1002%2FHUP.317

21 January 2018

Serotonergic compounds in panic disorder, obsessive-compulsive disorder and anxious depression: A concise review.

1 reference

https://api.crossref.org/works/10.1002%2FHUP.317

7 January 2021

based on heuristic

inferred from DOI database lookup

Obsessive-compulsive disorder. A double-blind trial of clomipramine and clorgyline

1 reference

https://api.crossref.org/works/10.1002%2FHUP.317

7 January 2021

based on heuristic

inferred from DOI database lookup

Obsessive-compulsive and related disorders: a hidden epidemic

1 reference

https://api.crossref.org/works/10.1002%2FHUP.317

7 January 2021

based on heuristic

inferred from DOI database lookup

Fluvoxamine versus clomipramine for obsessive-compulsive disorder: a double-blind comparison

1 reference

https://api.crossref.org/works/10.1002%2FHUP.317

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term pharmacotherapy of obsessive-compulsive disorder: a double-blind controlled study

1 reference

https://api.crossref.org/works/10.1002%2FHUP.317

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of drug treatment in obsessive-compulsive disorder. A meta-analytic review

1 reference

https://api.crossref.org/works/10.1002%2FHUP.317

7 January 2021

based on heuristic

inferred from DOI database lookup

Meta-analysis of pharmacotherapy trials for obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1002%2FHUP.317

7 January 2021

based on heuristic

inferred from DOI database lookup

Clomipramine Versus Fluvoxamine in Obsessive-Compulsive Disorder

1 reference

https://api.crossref.org/works/10.1002%2FHUP.317

7 January 2021

based on heuristic

inferred from DOI database lookup

A multicenter investigation of fixed-dose fluoxetine in the treatment of obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1002%2FHUP.317

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/HUP.317

1 reference

Europe PubMed Central

PubMed publication ID

18 April 2018

http://europepmc.org/abstract/MED/12404554

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

18 April 2018

http://europepmc.org/abstract/MED/12404554

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51952581&oldid=1501668538"